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                                                      ABSTRACT 
 
Cutis laxa (CL) is a rare connective tissue disorder associated with mutations in 
extracellular matrix genes that leads to loose, redundant, lax skin and is often accompanied 
by cardiovascular, pulmonary, musculoskeletal or neurological complications. Literature 
suggests that individuals with CL have distinctive craniofacial features. Prior reports have 
been inconsistent and to date no quantitative, objective analysis of the craniofacial 
phenotype has been carried out on this population. To address this deficit, state-of-the-art 
3-dimensional (3D) imaging was used to capture quantitative facial measurements in a 
sample of individuals with cutis laxa and compare the facial morphology of affected 
individuals to matched controls. The hypothesis that different forms of CL (acquired vs 
congenital) exhibit different craniofacial phenotypes was also tested. Subjects were 
recruited as part of the Genetics of Extracellular Matrix in Health and Disease Study and 
3D images of the head and face were acquired using a 3DMD portable 
stereophotogrammetry system. Twenty-four facial landmarks were identified on each 
subject’s 3D facial image, and from these landmarks, a set of standard anthropometric 
facial measurements was calculated. These shape coordinates were then subjected to 
principal components analysis to quantify and compare the major aspects of facial shape 
variation within and among groups. Congenital CL showed marked narrowing and 
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lengthening of the face and subjects with ELN mutations had the most severe facial 
phenotypes. The craniofacial shape did not correlate with the individual’s skin elasticity 
supporting the conclusion that the craniofacial phenotype of CL is primarily caused by 
altered craniofacial development rather than skin laxity.  The public health significance of 
this study is that craniofacial dysmorphism can occur as a part of many genetic syndromes. 
This type of quantitative study can be applied to any genetic disease with a distinct 
craniofacial phenotype and may assist the development of accurate, objective, sensitive 
and specific diagnostic criteria. 
v  
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1.0  INTRODUCTION 
1.1 CUTIS LAXA: SUB-TYPES AND CRANIOFACIAL FEATURES 
Cutis laxa is a rare connective tissue disorder characterized by generalized or localized lax skin, 
premature wrinkling or aging of the skin, redundant skin folds, cardiovascular issues, pulmonary 
complications, or musculoskeletal features.  The true prevalence is not known but an estimate of 
1:4,000,000 for all congenital types of cutis laxa has been reported in the Rhone-Alpes Eurocat 
Registry (E Robert, personal observation).  Cutis laxa may be classified into two broader 
categories: congenital and acquired.  Congenital cases have inherited or de novo mutations that 
cause cutis laxa visible at birth, whereas the acquired form is not fully understood; however, a 
life event occurs that causes cutis laxa later on in adulthood.  It is a heterogeneous condition that 
may be divided into many different subtypes (Berk et al., 2012).   
Several reports have described distinct craniofacial features in CL populations.  These 
reports have generally been “qualitative” in nature and a systemic assessment of the craniofacial 
phenotype has been lacking.  Below we will summarize the different forms of cutis laxa, 
focusing on their etiology, and what, if anything is known about their craniofacial phenotype.  It 
is important to characterize the craniofacial phenotype for cutis laxa because it is a rare condition 
that few healthcare professionals will encounter during his/her career.  As a result, this condition 
may not be recognized through a physical exam and consequently not be diagnosed.  This study 
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could be the foundation of characterizing and quantifying the facial features of CL to make the 
phenotype well known and be used for diagnostic purposes in the future. 
1.1.1 Autosomal Dominant Cutis Laxa (ADCL) 
ADCL is caused by mutations in the elastin (ELN) gene, which codes for a protein called 
tropoelastin.  The tropoelastin protein forms elastin, which is a mature protein polymer and 
builds an individual’s elastic fibers.  The mutation was first identified by Tassabehji et al (1998).  
This study found a novel frameshift mutation and performed EM (electron microscopy) 
suggesting the mutant tropoelastin protein changes formation of elastin fibers once incorporated 
in the matrix (Tassabehji et al., 1998). Another study built on this and discovered additional ELN 
mutations in ADCL (Zhang et al., 1999). 
Because elastic fibers give structural support to the skin, heart, lungs, and blood vessels, 
individuals with autosomal dominant cutis laxa may have lax skin, cardiovascular concerns such 
as aortic root dilatation, pulmonary complications like emphysema, and inguinal hernias 
(Callewaert et al., 2011; He et al. 2012).  Individuals with an ELN mutation have been described 
as having a long face, large pliant ears, and a long philtrum.  Individuals may also have a beaked 
nose and blepharochalasis or eyelid inflammation and ptosis or drooping of the upper eyelid 
often occurs (Hadj-Rabia et al., 2013).  Autosomal dominant cutis laxa causes patients to have a 
prematurely aged appearance of the face (Uitto et al., 2013).  They have also been described as 
having a coarse face with bitemporal narrowness, low nasal bridge, flat broad nose, periorbital 
fullness, full cheeks, high palate, general skin laxity especially in the face and buttocks, and lax 
abdominal musculature (Graul-Neumann et al., 2007).  Usually, the skin’s appearance is the 
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focus and reported as an aged appearance with loose redundant skin folds of the cheeks and chin, 
a high forehead, a long philtrum and large ear lobes (Callewaert et al., 2011). 
1.1.2 Autosomal Recessive Cutis Laxa 1A (ARCL1A) 
ARCL1A is caused by mutations in the fibulin-5 (FBLN5) gene.  A homozygous missense 
mutation was first reported to cause this type of cutis laxa.  When analyzing individuals from a 
large family, the mutation segregated with this disease (Loeys et al., 2002).  The FBLN5 gene 
codes for a protein called fibulin-5 that assists with the assembly of elastic fibers and in adults 
can be found in skin, aorta, lung, and uterus (Yanagisawa et al., 2002; Kowal et al., 1999).  
Fibroblast studies verified the protein’s role in creating elastic fibers, and confirmed the 
significance of pathogenic, missense mutations that have a loss of function effect (Hu et al., 
2006; Claus et al., 2008).  Individuals with autosomal recessive cutis laxa 1A may have loose 
skin, hernias, developmental emphysema and supravalvular aortic stenosis (Loeys et al., 2002).  
Phenotypic facial features have been reported such as an aged appearance of the skin including 
the face, bilateral ptosis, drooping cheeks, large ears, and a small mouth (Claus et al., 2008).   
1.1.3 Autosomal recessive cutis laxa 1B (ARCL1B) 
ARCL1B is caused by mutations in the fibulin-4 (FBLN4) gene, which codes for a protein 
component of the elastic fibers.  A homozygous missense mutation was identified and the effects 
of the mutation were explored using fibroblasts and analyzing mRNA expression.  A decrease of 
fibulin-4 protein was found in the extracellular matrix of the cultured fibroblasts (Hucthagowder 
et al., 2006). Studies looking at compound heterozygous mutations found a lack of fibulin-4 in 
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the extracellular matrix of cultured fibroblasts.  As a result of these mutations, an unstable 
mutant protein and an unstable mRNA were produced (Dasouki et al., 2007). Skin fibroblasts 
from individuals with FBLN4 mutations show increased activity of the TGFβ signaling pathway 
(Renard et al., 2010).  Kappanayil et al. (2012) conducted a study with 22 subjects and identified 
two mutations in fibulin-4.  Individuals with autosomal recessive cutis laxa 1B can have a severe 
phenotype that includes lax skin, aneurysms of the aorta, arterial tortuosity, inguinal hernias, 
hypermobility, and emphysema. Case reports have shown a homozygous premature stop codon, 
which yields multiple bone fractures, tortuous arteries, and generalized cutis laxa (Erickson et 
al., 2012). Craniofacial features that have been reported include loose, flabby cheeks and 
hypoplasia of the lower jaw, a hooked nose, small palpebral fissures and dysplastic ears (Sawyer 
et al., 2012; Hoyer et al., 2009).   
1.1.4 Autosomal recessive cutis laxa 1C (ARCL1C)  
ARCL1C is caused by mutations in the latent transforming growth factor beta binding protein 4 
(LTBP4) gene. Defects in this gene cause lax skin, severe emphysema, gastrointestinal, 
genitourinary, and musculoskeletal issues. Premature stop codon mutations are frequently found 
in LTBP4 causing greatly reduced mRNA expression.  In LTBP4 deficient tissues and cell 
cultures the elastic fibers are disorganized and the amount of TGF-β released from the 
extracellular matrix is increased (Urban et al., 2009). Individuals with autosomal recessive cutis 
laxa 1C have been reported to have a sloping forehead, sparse hair on the temporal sides, large 
ears, hypertelorism, a low nasal bridge, a beaked nose, sagging cheeks, and retrognathia 
(Callewaert et al., 2012). 
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1.1.5 Autosomal recessive cutis laxa 2A (ARCL2A) 
ARCL2A is caused by mutations in the gene for the a2 subunit of the lysosomal proton 
transporter ATPase, (ATP6V0A2), which codes for a component of a protein complex 
responsible for secretory vesicle acidification.  Mutations in ATP6V0A2 result in a loss of 
function and abnormal organization of the Golgi apparatus.  Patients with ARCL2A also have 
altered glycosylation of serum proteins (Kornak et al., 2008).   Individuals with autosomal 
recessive cutis laxa 2A may have features including lax skin, hip dislocations, hernias, myopia, 
severe developmental delay, and seizures (Hucthagowder et al., 2009).  Their craniofacial 
phenotype has been described as a triangular-shaped face, downslanting palpebral fissures and a 
broad nasal root (Fischer et al., 2012). 
1.1.6 Autosomal recessive cutis laxa 2B (ARCL2B) 
ARCL2B is caused by mutations in the gene for pyrroline-5-carboxylate reductase 1 (PYCR1), a 
mitochondrial enzyme necessary for proline biosynthesis (Reversade et al., 2009).  Reversade et 
al. in 2009 found highest levels of PYCR1 expression in the skin and bone and mutations caused 
a loss of function of the protein.  Guernsey et al. (2009) identified a missense mutation in the 
PYCR1 gene that led to exon skipping.  A further study gathered 33 individuals from 27 families 
to examine the clinical features and found that hypotonia, IUGR (intrauterine growth 
retardation), and psychomotor retardation coupled with certain facial features could provide 
clues for a potential diagnosis (Dimopoulou et al., 2013).  An individual may have features 
including lax skin, growth delay, joint and skeletal problems, developmental delay, and 
microcephaly.  There are reports of lax face, broad forehead, midface retrusion, prognathism, and 
 5 
large protruding ears (Yildirim et al., 2011).  Another study mentioned a triangular face, blue 
sclerae, prominent ears, and microcephaly while another study reported prominent forehead, 
protruding ears, myopia, and esotropia (Kouwenberg et al., 2011; Lin et al., 2011). 
1.1.7 Autosomal recessive cutis laxa 3 or De Barsy syndrome (ARCL3)  
ARCL3 is caused by mutations in the aldehyde dehydrogenase 18 family, member A1 
(ALDH18A1) gene, which codes for a protein required for the biosynthesis of proline, ornithine 
and arginine.  Bicknell and co-workers studied a homozygous missense mutation, p.H784Y, 
predicted to be deleterious by the SIFT software.  The effect of this mutation in ALDH18A1 is 
not currently understood (Bicknell et al., 2008). Features of ARCL3 include lax skin, growth 
retardation, moderate to severe intellectual disability, cataracts, and joint laxity.  The craniofacial 
phenotype in ARCL3 has been described as a high forehead with frontal bossing, depressed nasal 
bridge, short upturned nose with hypoplastic nasal alae, and thin lips as well as deep set eyes, 
corneal clouding, prominent cheek jowls, high-arched palate, and micrognathia (Skidmore et al., 
2011). 
1.1.8 MACS syndrome 
MACS syndrome was named after its major manifestations including macrocephaly, alopecia, 
cutis laxa, and scoliosis (Basel-Vanagaite et al., 2009).  Therefore, an individual may have 
features including lax skin, macrocephaly, alopecia, and scoliosis, and joint laxity.  This form of 
cutis laxa is caused by mutations in the Ras and Rab interactor 2 (RIN2) gene (Basel-Vanagaite 
et al., 2009). For example, a homozygous frameshift mutation was identified causing RIN2 
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protein production to be reduced (Basel-Vanagaite et al., 2009).   Syx et al. (2010) identified a 
RIN2 mutation, which caused a premature stop codon and as a result, nonsense-mediated decay 
of the mRNA.  However, when reviewing the clinical findings of these patients in this study, the 
authors thought that three individuals did not exhibit cutis laxa of the skin.  They proposed that 
MACS syndrome may not be the most appropriate name and argued that this condition is more 
similar to Ehlers-Danlos syndrome (Syx et al., 2010). Thus, the precise classification of 
RIN2/MACS syndrome remains unclear.  Studies have commented on the craniofacial phenotype 
being facial coarsening and macrocephaly, downslanting palpebral fissures, puffy droopy 
eyelids, and full lips (Basel-Vanagaite et al., 2009; Syx et al., 2010). 
1.1.9 X-linked recessive form: occipital horn syndrome (OHS) 
This form of CL is caused by mutations on the X chromosome and is a milder variant of Menkes 
disease, which is a defect of copper metabolism.  In OHS, low ceruloplasmin and serum copper 
levels may be present.  This disorder is caused by mutations in the ATP7A gene, encoding a 
copper transporter.. Studies in the early 1990s analyzed a splice mutation that was thought to 
yield a milder phenotype than Menkes.  The amount of mRNA was found to be reduced but not 
completely absent.  A possible explanation was that some level of normal splicing was occurring 
allowing for some remaining protein function (Kaler et al., 1994). Further investigation of OHS 
confirmed that splicing was involved and the disorder can be considered a milder variant of 
Menkes disease (Das et al., 1995). Two novel missense mutations were reported within 
individuals with distal motor neuropathy in the absence of obvious copper deficiency (Kennerson 
et al., 2010).  One study reviewed mutations previously reported in the literature (Tumer, 2013).   
Individuals who have OHS may have hernias, skeletal abnormalities, joint laxity, and bladder 
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diverticula. The most notable feature is the occipital horns, which may become more apparent as 
these individuals age. The craniofacial phenotype is not well described but reports of kinky hair 
have been made for Menkes patients while OHS patients have occipital bony abnormalities, 
dolichocephaly, prominent ears, downslanting palpebral fissures, and ptosis (Tumer, 2013). 
1.1.10 Arterial tortuosity syndrome (ATS) 
ATS is caused by mutations in the solute carrier family 2 (facilitated glucose transporter), 
member 10 (SLC2A10) gene, which codes for a protein called GLUT10, involved in bone and 
blood vessel development (Coucke et al., 2006).  An individual with arterial tortuosity syndrome 
may have features including tortuous arteries with an increased risk of aneurysms and stenosis.  
The craniofacial phenotype is described as having acrogeria, a long face, sagging cheeks, thin 
nose with hypoplastic alae nasi, bilateral lower blepharochalasia and mild blepharophimosis 
(Castori et al., 2012). 
1.1.11 Craniofacial phenotype in Cutis Laxa 
There are many shared facial features among these subtypes of cutis laxa.  The majority 
demonstrate an aged appearance due to premature wrinkling and sagging skin.   However, these 
features are difficult to characterize due to the lack of quantitative analysis.  The current 
qualitative reports are subjective in nature as individuals employ different descriptive terms that 
overlap.  For example, drooping cheeks are the most common feature seen in ADCL, ARCL1A, 
ARCL1B, ARCL1C, ARCL3, and ATS but the terms flabby, sagging, and full are all utilized to 
describe the same feature (Graul-Neumann et al., 2007; Claus et al., 2008; Sawyer et al., 2012; 
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Hoyer et al., 2009; Callewaert et al., 2012; Skidmore et al., 2011; Castori et al., 2012).  Other 
common features include a long face in ADCL and ATS, prominent ears in ADCL, ARCL1A, 
ARCL1C, ARCL2B, and OHS, and ptosis in subtypes ADCL, ARCL1A, MACS syndrome, and 
OHS (Hadj-Rabia et al., 2013; Claus et al., 2008; Callewaert et al., 2012; Yildirim et al., 2011;  
Tumer, 2013).  Additional shared features include a hooked nose for subtypes ADCL, ARCL1B 
and ARCL1C, triangular-shaped face in ARCL2A and ARCL2B, and frontal bossing in 
ARCL2B and ARCL3 (Table 1) (Hadj-Rabia et al., 2013; Sawyer et al., 2012; Hoyer et al., 2009; 
Callewaert et al., 2012; Fischer et al., 2012; Kouwenberg et al., 2011; Lin et al., 2011; Skidmore 
et al., 2011).  However, depending on the expertise of the person reporting the features, some 
may be overlooked or remain unreported.  Furthermore, some craniofacial characteristics may 
not appear abnormal but still may be distinct from controls in quantitative analysis, and it is these 
features that could be missed by case reports.  It is important to review the various phenotypes 
because although there are some shared features among them, each subtype has a different 
craniofacial phenotype, which can be quantified.  If this is well characterized, genotype-
phenotype correlations will be better understood and healthcare professionals could not only 
diagnosis CL patients but predict what mutation the individual should have before undergoing 
genetic testing. 
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Table 1. Subtypes of CL, causative gene, and craniofacial features 
Type Gene Features 
ADCL ELN Aged appearance, long 
philtrum and face, large ears 
ARCL1A FBLN5 Aged appearance, bilateral 
ptosis, drooping cheeks, large 
ears, small mouth 
ARCL1B FBLN4 Flabby cheeks, lower jaw 
hypoplasia, hooked nose, 
small palpebral fissures, 
dysplastic ears 
ARCL1C LTBP4 Sloping forehead, sparse hair, 
large ears, hypertelorism, low 
nasal bridge, beaked nose, 
sagging cheeks, retrognathia 
ARCL2A ATP6V0A2 Triangular-shaped face, 
downslanting palpebral 
fissures, broad nasal root 
ARCL2B PYCR1 Lax, triangular face, broad 
forehead, midface retrusion, 
prognathism, large protruding 
ears, myopia, and esotropia 
ARCL3 ALDH18A1 Frontal bossing, depressed 
nasal bridge, short upturned 
nose with hypoplastic nasal 
alae, thin lips, saggy cheeks, 
and micrognathia 
MACS syndrome RIN2 Facial coarsening, 
macrocephaly, downslanting 
palpebral fissures, puffy, 
droopy eyelids, and full, 
everted lips 
Occipital Horn Syndrome 
(OHS) 
ATP7A Occipital bony abnormalities, 
dolichocephaly, prominent 
ears, downslanting palpebral 
fissures, ptosis 
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1.2 CRANIOFACIAL PHENOTYPES IN OTHER CONNECTIVE TISSUE 
DISORDERS 
1.2.1 Williams-Beuren syndrome (WBS) 
This condition is caused by a deletion of 7q11.23 (Ewart et al., 1993).  Both ELN and GTF2IRD1 
are within the deleted region.  The craniofacial phenotype of WBS is characterized by bitemporal 
narrowing, a broad forehead, flattened malar, puffy appearance of the periorbital region, wide 
mouth and nasal tip, long philtrum, full cheeks, and micrognathia (Ewart et al., 1993).  
Homozygous deletion of GTF2IRD1 results in face abnormalities in mice, similar to the 
craniofacial phenotype for people with WBS.  GTF2IRD1 controls expression of 2 genes that are 
involved in bone and craniofacial development: Gsc (goosecoid) and Hoxc8 (Tassabehji et al., 
2005).  However, the contribution of ELN haploinsufficiency, if any, to the WBS craniofacial 
phenotype remains to be determined. 
1.2.2 Marfan syndrome (MFS) 
MFS is caused by mutations in fibrillin-1 gene (FBN1) (Kainulainen et al., 1990; Sood et al., 
1996). A morphometric analysis of MFS patients identified retrognathia, high palate, and dental 
issues such as root deformities (De Coster et al., 2004).  Motohashi created a system where 
certain diseases associated with dysmorphology would have the ability to be studied 
quantitatively using a schematic diagram to take measurements of the head (Motohashi, 1985).  
How to specifically study and quantify craniofacial growth in this population was also 
investigated (Grewe et al., 1971).  Craniofacial abnormalities in Marfan patients were studied in 
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a group of 15 adults and found to be prevalent within this population and also an association with 
obstructive sleep apnea was discovered (Cistulli et al., 2001).  When the specific abnormalities 
were quantified, the palate was found to be high and narrow and the lower jaw retrognathic 
(Wrestling et al., 1998; Poole, 1989).  Further studies confirmed that the palate in patients with 
Marfan syndrome was larger and taller than individuals without this condition. A characteristic 
long face was also found to be associated with this connective tissue disorder (De Coster et al., 
2004).   
1.3 QUANTITATIVE ANALYSIS OF CRANIOFACIAL FEATURES 
1.3.1 Direct anthropometry 
Traditionally, handheld calipers have been used to measure the craniofacial complex (Farkas, 
1994).  This is considered direct anthropometry because the measurement method requires direct 
contact with the subject’s head and face.  While highly reliable and inexpensive, this approach to 
measurement has several drawbacks.  It can be invasive and very difficult to perform on 
uncooperative subjects.  It can also be quite time consuming, requiring patients to remain still for 
long periods of time (Wong et al., 2008). 
1.3.2 Digital 3D stereophotogrammetry 
Stereophotogrammetry involves quantifying objects from photographs. In recent years, 3D 
stereophotogrammetry has become a popular technique for capturing the geometry of the facial 
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surface (Heike et al., 2010).  Based on relatively simple principles of triangulation, 3D 
stereophotogrammetry is a non-invasive acquisition method capable of very fast captures (less 
than 1 second).  Commercially available systems allow users to capture photorealistic and 
geometrically accurate 3D maps of the human face and provide software allowing users to 
manipulate and quantify the resulting surfaces.  Compared with direct anthropometry, this 
method is preferred when conducting routine facial imaging as it reduces the amount of time 
required for collecting the data and allows for numerous quantification methods following 
capture (Artopoulos et al., 2013; Maal et al., 2010).  Additionally, digital 3D 
stereophotogrammetry is desirable because it is easily reproduced (Maal et al., 2011); this 
technology has been studied and validated by numerous independent studies (Weinberg et al., 
2004; 2006; Aldridge et al., 2005; Losken et al., 2005; Wong et al., 2008; Heike et al. 2009). 
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 Figure 1. An example of a 3D model without texture 
1.4 SPECIFIC AIMS 
If individuals with cutis laxa exhibit distinctive craniofacial features, then it should be possible to 
quantify them.  To date, no studies have focused specifically on the cutis laxa craniofacial 
phenotype.  In the current literature, facial features are only briefly mentioned with inconsistent 
qualitative descriptions.  To address this deficit, this study will use modern phenotyping methods 
(3D imaging and advanced morphometric methods) to provide a more complete understanding of 
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the craniofacial complex in cutis laxa.  An improved understanding may offer additional insights 
into the phenotypic similarities and differences among subtypes of cutis laxa and the possible 
role of extracellular matrix genes and proteins in craniofacial development.  For this study, we 
hypothesized that different forms of CL will present distinct craniofacial phenotypes suggesting 
possible genotype-phenotype correlations.  The following specific aims were proposed: 
1. Conduct a quantitative evaluation of facial shape in a cohort of individuals with 
CL using a portable 3D stereophotogrammetry system. 
2. Compare the craniofacial shape of CL patients to matched controls using a 
geometric morphometric approach. 
3. Investigate if craniofacial features correlate with the type of CL, the specific gene 
defect involved or with objective measures of skin laxity. 
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2.0  MATERIALS AND METHODS 
Institutional Review Board (IRB) approval for this study was obtained at the University of 
Pittsburgh, and the approval letter may be found in Appendix A.  The Genetics of Extracellular 
Matrix in Health and Disease is currently funded through the NIH. 
2.1 CLINIC PROTOCOL 
2.1.1 Recruitment 
Participants were either self-referred or referred by physicians and/or genetic counselors who 
contacted the research team.  Additional participants were recruited through an online support 
group or through relatives of a family already enrolled into the research study. Once all the 
necessary contact information was gathered and the individual had a clinical or probable 
diagnosis of cutis laxa or had a first degree relative with a clinical or probable diagnosis, a 
screening process occurred to determine eligibility.  This procedure was conducted over the 
telephone with the participant where he/she was asked a series of questions about his/her skin or 
his/her first degree relative’s skin: does he/she have loose, lax skin, skin in redundant folds, 
inelastic or doughy skin, premature aging of the skin, or excessive premature wrinkling.  If an 
individual answered “yes” to at least three of these questions, then he/she was eligible for 
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participation in the research study.  If he/she did not answer “yes” to at least three of these 
questions, then additional questions about family member’s other organ systems were asked: any 
arterial tortuosity, aneurysms, emphysema, spinal disease, diverticula, or hernias.  If the subject 
answered “yes” to at least one of these questions then he/she was eligible.  The next step was 
gathering demographic and diagnosis-related information from the subject including confirming 
participant’s contact information, age of onset for the cutis laxa, and if a diagnosis was made, 
name and contact information of the physician who made the diagnosis. 
2.1.2 Informed Consent 
Once the participant was determined to be eligible, informed consent was obtained. This 
involved reviewing and explaining each section of the consent form (describing the purpose of 
the study and the research clinic) with the participant and answering any questions.  If the 
participant attended a research clinic through the University of Pittsburgh Medical Center, then 
the individual was re-consented (including reviewing all research testing that would be 
performed) in person before any research activities were carried out.  The participant and the 
person obtaining consent signed the consent form before any research activities were performed.    
2.1.3 Research Activities 
Any activity that was completed depended upon whether the subject was participating remotely 
via his/her physician or attending a research clinic in Pittsburgh.  However, all facial imaging 
was completed in Pittsburgh. 
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2.1.3.1 Affected Individuals’ Participation through Research Clinics  
When an individual attended a cutis laxa research clinic in Pittsburgh, activities included a cutis 
laxa questionnaire which covered personal medical history and pedigree, blood (or, less often, 
saliva) sample and vitals (measuring height, weight, and blood pressure), genetics evaluation 
including two skin punch biopsies, craniofacial imaging, skin and vascular elasticity testing, a 
private meeting with the principal investigator, lymphedema measurements, pulmonary function 
test (PFT) and chest computed tomography (CT), respiratory questionnaires, echocardiogram, 
and DEXA scan.  All of these tests were performed at the Clinical and Translational Research 
Center in Montefiore Hospital with exception of the chest CTs, which were completed at the 
Hillman Cancer Center.   
Early in the clinic visit participants’ vitals (height, weight, and blood pressure) were 
taken and his/her blood drawn for DNA, plasma, and serum isolation.  In some cases, a saliva 
sample was also collected for DNA isolation (if blood could not be taken).  The genetics 
evaluation was carried out by trained genetics personnel and consisted of a physical exam.  The 
photographs were obtained with permission and the cutis laxa questionnaire was filled out (see 
Appendix B).  This questionnaire obtained the pedigree, personal medical history, and review of 
systems.  After the exam, a skin biopsy was obtained from participants who were willing and 
cells were not already available from a previous biopsy.  Biopsies were used for histology, 
electron microscopy (EM), and growing fibroblasts.   
Craniofacial imaging was performed using a 3dMDface digital 3D stereophotogrammetry 
system (Atlanta, GA).  This testing was done on any affected individual who could remain still 
for at least five minutes with the youngest participant being 2 years old and is described in 
greater detail in section 2.3. 
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Skin elasticity testing consisted of using a DermaLab skin elasticity module that 
measured how elastic the skin was (elastic modulus, viscoelastic modulus, and retraction time).  
This testing was performed on all affected individuals who could remain still for at least 10 
minutes.   
2.1.3.2 First-Degree Relatives’ Participation 
Unless these relatives were known heterozygous carriers for a recessive mutation, for example, 
in LTBP4, participation involved receiving informed consent and giving a blood or saliva sample 
in order to complete genetic testing and confirm the results of the proband or to compare when 
performing whole exome sequencing.  If the individuals were carriers, the participants received 
the same testing as individuals with cutis laxa.   
2.2 LABORATORY PROTOCOLS 
2.2.1 Mutation Analysis 
DNA was isolated for each participant for mutation analysis.  This analysis was completed 
usually from peripheral blood, or in some cases on saliva or cultured fibroblasts from a skin 
biopsy.  Isolation was achieved utilizing phenol chloroform extraction or the PureGene System 
(Qiagen) for blood samples, and the Oragene protocol (DNA Genotek) for saliva samples.  DNA 
concentration for the preparation was measured by UV spectrophotometry.  Working solutions 
were prepared at a standard concentration of 50 ng/μl.  Target gene sequences of ELN, FBLN4, 
FBLN5, LTBP4, ATP6V0A2, or PYCR1 which included exons and flanking parts of introns were 
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amplified by PCR. ExoSAP-IT and ABI BigDye Terminator Kit (Applied Biosystems) were 
employed for cleaning the PCR product and for the sequencing reaction, respectively.  Sense and 
antisense strand sequencing was completed using the University of Pittsburgh Genomics and 
Proteomics core facility.  Sequencher (Gene Codes Corporation) and the UCSC Genome 
Browser were employed for analysis.  Mutations were confirmed using separate amplification 
products and, if necessary, through RNA studies. 
2.3 3D FACIAL IMAGING 
2.3.1 The Participants 
33 subjects with confirmed or suspected cutis laxa ranging in age from 2-70 years were recruited 
as part of the Genetics of Extracellular Matrix in Health and Disease Study at the University of 
Pittsburgh and attended a cutis laxa research clinic.     
2.3.2 The Imaging Process 
As part of the research testing, 3D images of the head and face were obtained using a 3dMDface 
portable stereophotogrammetry system.  The unit consists of six medical grade digital cameras 
with overlapping fields of view that simultaneously capture the face. Almost concurrently a high 
resolution color image of the face is acquired.  These images are fed into a laptop with image 
processing software that automatically aligns the various images into a complete 3D model.  The 
result is a dense 3D point cloud representing the complete 180-degree surface geometry of the 
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human face.  To enhance visualization, this point cloud is then connected into a 3D mesh.  This 
mesh is then filled in to create an airtight 3D surface and the pixels from the color images are 
mapped onto the geometry to give the 3D facial surface lifelike skin texture and color.  The 
entire acquisition process takes place in less than 4 milliseconds.  The post-acquisition 
processing takes an additional 20 seconds. 
Great care was taken in preparing participants for the 3D photographs by positioning 
them in the ideal position with respect to the camera and removing any hair that was obstructing 
the face with a headband and/or clips.  Participants were told to look at the camera straight on, 
remain still, and do not smile.  After the image was taken, it was reviewed for quality and a 
second image was taken if necessary (if the participant had moved, mouth was open, etc.).   All 
imaging was performed by trained personnel.   The images were then transferred to the 3D 
Imaging and Morphometrics Lab within the Center for Craniofacial and Dental Genetics, School 
of Dental Medicine. 
2.3.3 Landmarking  
The subjects’ 3D images were “cleaned” by removing any unnecessary portions of the facial 
images such as a subject’s shirt, bottom of neck, or sections of hair using the 3dMD-Patient 
software package. Using 3dMDVultus software, 24 standard anatomical landmarks were then 
identified on each subject’s 3D facial image: these included the (1) nasion, (2) pronasale, (3) 
subnasale, (4) labiale superus, (5) stomion, (6) labiale inferus, (7) sublabiale, (8) gnathion, (9, 
10) endocanthion (right and left), (11, 12) exocanthion (right and left), (13, 14) alare (right and 
left), (15, 16) alar curvature point (right and left), (17, 18) subalare (right and left), (19, 20) crista 
philtri (right and left), (21, 22) chelion (right and left), and (23, 24) tragion (right and left). The 
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coordinate positions (x,y,z) associated with the landmarks were then saved as text files for later 
analysis.   
After each 3D image was landmarked, the placement of every landmark on all subjects’ 
facial images was verified by a second rater for quality control.  As an additional quality control 
measure, all raters undergo training prior to landmarking.  This involves collecting the full set of 
24 landmarks twice on an independent set of 20 subjects and evaluating the intraobserver error of 
the landmark placement.  Intraclass correlation coefficients of .90 or greater must be achieved for 
every landmark in each of the three principal coordinate axes (x,y,z) in order to proceed with 
data collection.  As another precaution after the landmarks had been placed on each subject, a 
‘Landmark Collection Form’ was completed, which is a fillable pdf form used to create notes 
about missing regions, reasons why a landmark was not placed, or other details that would assist 
another person in understanding the choices an individual made while landmarking.   
 
Figure 2. Landmarked facial image (15, 16 cannot be shown on this 2D surface) 
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2.3.4 Statistical Analysis  
Following landmarking, the cutis laxa dataset was reviewed and individuals who met any 
exclusion criteria were removed from the sample.  The exclusion criteria were the following for 
the cutis laxa cases: history of major facial surgeries, non-Caucasian ancestry (because non-
Caucasian controls did not exist in the database), missing data due to poor 3D image, unaffected 
carriers of a recessive form of cutis laxa, and individuals who did not have a definitive diagnosis 
of cutis laxa. Based on these criteria the sample size was reduced from 33 to 10 subjects:  five 
congenital cases of cutis laxa and five acquired cases of cutis laxa.  8 individuals were removed 
due to ancestry, 5 participants were removed for a history of major facial surgeries (including 
rhinoplasty, multiple facelifts, jaw and chin surgery, and multiple injections and fillers), 5 did not 
have a clinical diagnosis of cutis laxa, 3 individuals were unaffected carriers, 1 individual had 
missing data due to a poor 3D image, and 1 participant was an outlier and was removed from the 
sample set.  The next step in this process was to compare these cases to demographically-
matched controls obtained through the 3D Facial Norms Project (PI: Seth Weinberg), a database 
of 3D facial images, landmarks, and measurements comprised of over 2400 healthy individuals 
between age 3 and 40.  These controls also had their own set of exclusion criteria: history of 
significant facial trauma or facial surgery, personal or family history of a craniofacial syndrome 
or birth defects, missing data due to poor 3D image, and non-Caucasian ancestry.  Based on 
these criteria, four controls matched on age, sex, and ethnicity to each cutis laxa case were 
identified for a total sample size of 50: 10 cases and 40 controls.  A t-test confirmed that the ages 
did not differ between the two groups (see Table 2 in Results).   
A geometric morphometric analysis was then carried out on the landmark coordinate 
data. Briefly, the 3D facial landmark coordinates for all 50 subjects were registered to one 
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another using the Procrustes superimposition method.   The process removes scaling effects from 
the coordinate data and ensures that all of the subjects are located within the same coordinate 
space.  The newly transformed coordinates represent shape. Principal component analysis (PCA) 
was then applied to the shape coordinates in order to summarize the major modes of shape 
variation (shape components) present within the entire dataset.  By plotting the scores on each 
extracted principal component against one another, it is possible to identify those components 
capable of distinguishing groups.  As a follow-up analysis, a subset of seven landmarks 
comprising the nose and philtrum was subjected to canonical variates analysis (CVA).  This 
approach looks for the best combination of variables (in this case shape coordinates) that 
discriminate across groups most efficiently.  Both PCA and CVA are multivariate data reduction 
approaches. 
One of the advantages of geometric morphometrics is that the data used in the analysis 
(x,y,z coordinates) contain intrinsic geometric qualities.   Because of this, the shape variation 
uncovered by the PCA and CVA can be modeled as deformations of the average shape.  This 
means that once a PC or CV is determined to be important for distinguishing between the groups 
of interest, the associated shape changes involved can be visualized.  This can be done using 
wireframes for simple visualization or surface warps for more intuitive perspective.  In the 
present study, the program MorphoJ was used for all geometric morphometric analyses and the 
program Landmark was used to generate the surface warps based on the PCA and CVA results. 
To determine whether an association existed between a patient’s skin elasticity and 
craniofacial shape in the cutis laxa sample, Pearson correlation coefficients were calculated.  
This can measure the dependence between two variables and then determining p values can 
evaluate statistical significance.  The specific components of skin elasticity selected were 
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viscoelastic modulus (VE), elastic modulus (E), and retraction time (RT).  V and E are  measures 
of how easy it is to deform the skin and RT is the amount of time it takes the skin to return to its 
original position.  D is a composite variable that differentiates controls from cases the best.  The 
formula for D is: -27.570 + 0.187 x Age + 2.795 x VE + 1.267 x E.  These measures of skin 
elasticity were compared to the scores on any PCs or CVs that showed strong evidence of 
separating cutis laxa cases from controls.   
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3.0  RESULTS  
After applying the exclusion criteria, 10 individuals remained: 5 congenital cutis laxa cases (2 
with ELN mutations, 2 with LTB4 mutations and 1 with an unknown mutation) and 5 acquired 
cutis laxa cases.  A t-test confirmed that the ages did not differ significantly between cases and 
controls (Table 2). 
Table 2. Sample size and age 
Group N Age (years) SD P value 
Cases 10 35.9 20.1 0.991 
Controls 40 35.8 19.3  
N: sample size, Age: mean age, SD: standard deviation. 
The first principal component (PC1) explained 22.7% of the facial shape variation.  PC1 
appears to show congenital cases separating from the acquired cutis laxa cases (Figure 3).  
However age was the primary driver of shape variation in this component; acquired cases tend to 
be on the older end of the age spectrum.  PC2 explained 18.2% of facial shape variation.  PC2 
showed acquired cases and controls clustering together while the congenital cases separated 
primarily from controls (Figure 3).  To confirm this pattern, the mean scores on PC2 were 
compared across the three groups with ANOVA - using Bonferonni pairwise comparisons (Table 
3); congenital cases significantly differed from controls (p = 0.016). 
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Figure 3. PCA plot and facial warps showing the variation associated with PC2. The facial shape 
associated with congenital CL is represented by the top face.  The control facial shape is represented by the bottom 
face.  Individuals with known mutations are identified by a circle (ELN) or arrows (LTBP4) 
 
Table 3. ANOVA test results comparing the scores on PC2 
Comparison P value 
Congenital vs acquired 0.441 
Congenital vs control 0.016 
Acquired vs control 0.150 
 
The facial shape variation associated with PC2 is shown in Figure 3.  Congenital cutis 
laxa is associated with excessive midface lengthening and narrowing.  The cutis laxa subjects 
 27 
with the most dysmorphic characteristics had ELN mutations, which suggest that ADCL may 
display the most distinct craniofacial phenotype. 
 
 
Figure 4. CVA of nose and philtrum shape 
 Canonical variate analysis (CVA) was applied to focus on the shape of the nose and the 
philtrum. As part of the CVA, a permutation test was used to examine group differences in 
overall mean shape. The congenital cases significantly differed from controls (p = 0.0006); no 
other groups differed (Table 4).  The first canonical variate (CV1) revealed congenital cutis laxa 
cases separating from controls and the acquired cases fell in between these two groups (Figure 
4).   CV1 was associated with variation in the width, length and projection of the nose and upper 
lip.  Confirming the findings from the PCA, congenital cutis laxa was characterized by an overall 
lengthening and narrowing through the central midface structures as well as reduced nasal 
projection and upper lip protrusion.   
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Table 4. Permutation test results comparing mean shape across groups 
Comparison Procrustes distance P value 
Congenital vs acquired  0.0544 0.1334 
Congenital vs control 0.0780 0.0006 
Acquired vs control 0.0332 0.5868 
 
Skin elasticity data was also analyzed to determine whether there was an association 
between the skin laxity and facial shape variation.  The sample set of 10 (5 congenital cases and 
5 acquired cases) was included in this analysis as limiting this to only congenital cases would 
greatly reduce the statistical power.  Certain measurements were utilized such as VE, E, RT, and 
D and compared to the scores on PC2.  The correlations were all of low to moderate magnitude; 
none were significantly different from zero (Table 5).   
Table 5. Pearson correlation coefficient and comparing skin elasticity measures with scores on PC2 
 Pearson Correlation P value 
PC2/D 0.338925 0.338095 
PC2/RT -0.28448 0.426479 
PC2/E -0.13388 0.714155 
PC2/VE 0.399776 0.252461 
 
 Skin elasticity data was compared to the scores on CVA1 as well and the correlations 
were all of low to moderate magnitude with the exception of CVA1/D.  None were significantly 
different from zero (Table 6), although the CVA1/D correlation approached significance. 
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Table 6. Pearson correlation coefficient and comparing skin elasticity measures with scores on CV1 
 Pearson Correlation P value 
CVA1/D 0.629756732 0.051049 
CVA1/RT 0.188894408 0.601409 
CVA1/E  0.129081572 0.722462 
CVA1/VE  -0.295949298 0.407974 
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4.0  DISCUSSION 
There are many genetic diseases that have a distinct phenotype that an expert, having seen many 
patients with the same condition, can recognize just by looking at an individual’s face.  For 
example, patients with Williams syndrome have an elfin appearance.  These individuals have 
bitemporal narrowing, a broad forehead, flattened malar region, puffy appearance around the 
periorbital region, wide mouth and nasal tip, long philtrum, full cheeks, and micrognathia (Ewart 
et al., 1993).  This condition has a discernable craniofacial phenotype and has been well 
documented.  Similarly, Marfan syndrome is a genetic disorder with a recognizable craniofacial 
phenotype.  These patients have long faces with a high-arched palate and retrognathia (Wrestling 
et al., 1998; Poole, 1989).  Cutis laxa, however, is less common than Marfan or Williams 
syndromes such that healthcare professionals rarely encounter individuals with this connective 
tissue disorder and therefore may have difficulty with recognizing this condition’s craniofacial 
phenotype.  As we have now demonstrated, cutis laxa does have distinct, quantifiable facial 
features, which will lead healthcare professionals to faster diagnosis.  If enough individuals with 
cutis laxa are documented, physicians may be able to predict what mutation an individual has 
based on facial phenotype before genetic testing is initiated. 
We saw excessive face lengthening and narrowing in individuals with congenital CL.  
Individuals with an ELN mutation had the most distinct facial phenotype as both individuals with 
greatest mid-facial difference had ELN mutations.  The quantitative findings here confirm the 
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long face and bitemporal narrowing that has been qualitatively reported for the ADCL facial 
phenotype (Graul-Neumann et al., 2007; Hadj-Rabia et al., 2013).  
Individuals with congenital CL displayed significantly less nasal projection, reduced 
upper lip protrusion and increased elongation of the philtrum than controls. In the literature, 
ADCL, ARCL1B, and ARCL1C patients have been described to have beaked, broad, and hooked 
noses, while ARCL3 has been described to have a short, upturned nose (Hadj- Rabia et al., 2013; 
Hoyer et al., 2009; Callewaert et al., 2012; Skidmore et al., 2011). Thus, the finding of reduced 
nasal projection is consistent with the reports in ADCL, ARCL1B, ARCL1C, and ARCL3.  
These individuals should have short noses (in the case of ARCL3) or noses with a drooping nasal 
tip (ADCL, ARCL1B, and ARCL1C). 
Because the observed changes in both the overall shape of the face and the morphology 
of mid-facial structures were present in both pediatric and adult patients, our findings implicate 
CL genes in craniofacial growth and development. As all CL genes identified to date influence 
elastin biosynthesis (Urban et al., 2014), and in our results patients with ELN mutations showed 
the greatest degree of facial alterations, our study highlights a previously unappreciated role for 
elastin in the development and growth of the face. Elastin and fibrillin microfibrils are joined to 
form elastic fibers in many tissues. Therefore, it is not surprising that Marfan syndrome, caused 
by mutations in fibrillin-1, is characterized by an elongated face shape (de Coster et al., 2004), 
similar to CL. Elastic fibers are known to be present in the perichodrium and periosteum and 
have been postulated to inhibit the elongation of bones (Gigante et al., 1999). Initially thought to 
be a simple mechanical effect, it is now known that fibrillin microfibrils and elastic fibers 
regulate the bioavailability of transforming growth factor beta (TGFβ) and bone morphogenetic 
protein (BMP) growth factors and thus regulate the proliferation and differentiation of 
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osteoblasts (Nistala et al., 2010), the main cell type responsible for bone formation. Unlike 
Marfan syndrome, CL is not characterized by dolichostenomelia and tall stature. Thus, elastin 
appears to regulate the growth of the cranial skeleton, but not of the long bones. 
Alterations in the shape of mid-facial structures in CL also shed light onto the role of 
elastin in the development of the nose, lip and philtrum. Long philtrum has been observed in 
Williams syndrome along with other craniofacial features (Ewart et al., 1993), which, based on 
comparative studies on patients with partial deletions and animal models has been attributed to 
the deletion of GTF2IRD1 gene, located within the Williams syndrome critical region 
(Tassabehji et al. 2005).  Our studies now implicate elastin as a determinant of philtrum length 
and a likely contributor to the Williams syndrome facial phenotype.   
The shape of the nose is largely determined by several cartilage bodies: the cartilage of 
the nasal septum, the lateral nasal, lesser alar and lower alar cartilages. These cartilages are held 
together by fibrous connective tissues, rich in collagen and elastic fibers (Han et al., 2004). The 
projection of the nose is primarily determined by the medial part (also known as medial crus) of 
the lower alar cartilage (Patel et al., 2013) and its ligamentous connections to the nasal septal 
cartilage and to the contralateral medial crus (Han et al., 2004). The relative sparsity of these 
ligamentous connections are thought to explain the decreased nasal projection in East Asians 
compared to individuals of European ancestry (Han et al., 2004). Similarly, limited nasal 
projection in individuals with CL may be related to the underdevelopment of nasal connective 
tissue. 
The lack of correlation between the craniofacial shape (CVA1 and PC2) and skin 
elasticity measures indicates that the changes in facial shape in individuals with CL are largely 
unrelated to skin elasticity. However, borderline association of D, a composite variable of skin 
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elasticity measures and age with the greatest power to discriminate individuals with CL and 
controls, was observed with CV1 (p value of 0.051). CV1 captured the shape of mid-facial 
structures including the philtrum and the lip, composed of soft tissues conceivably influenced by 
skin elasticity.   
A limitation of the present study is that the sample size was small; 10 participants 
remained after individuals were removed upon meeting exclusion criteria.  However, CL is a rare 
disease and so it will take a longer time to obtain a larger population to study with this particular 
connective tissue disorder.  A possible source of error is facial landmarking. This source of error 
was minimized by adhering to strict training and quality control criteria.  A limitation of the 
current approach is that only the outside surface of the face was visualized. Therefore, the 
relative contributions of soft tissues and skeletal elements to the facial phenotype of CL remain 
to be determined.  
Future studies should include increasing the number of participants within this data set by 
adding the craniofacial imaging of future CL research clinics to the existing data.  This would 
increase the power of the analysis.  Additionally, more information may be obtained about the 
correlation of craniofacial features and the specific gene defect responsible.  This could lead to 
strengthened genotype-phenotype information.  Other future directions may include comparing 
additional data to craniofacial imaging to determine new possible correlations.  One example 
could be the DEXA data from the CL research clinic where bone density would be analyzed.  If 
skin laxity has no bearing on the craniofacial phenotype, it would be beneficial to determine 
other possible factors that influence craniofacial development.  Finally, the specific role for cutis 
laxa genes in craniofacial development could be explored through molecular biology to expand 
on the current study. Using an animal model such as a transgenic mouse would be ideal as CL is 
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the result of a dominant negative effect. This experiment could be the foundation of more in-
depth quantitative analysis of the craniofacial phenotype for cutis laxa patients. 
4.1 PUBLIC HEALTH SIGNIFICANCE 
Rare diseases, by definition, individually affect fewer than 200,000 individuals in the US (NIH 
Office of Rare Diseases). However, because there are almost 7000 known rare diseases, the total 
number affected persons are estimated to be over 25 million nationally. Patients are often 
misdiagnosed or undiagnosed and suffer from early onset, chronic, debilitating conditions 
commonly leading to early death. In many cases, the causes of rare diseases are unknown. 
Pharmaceutical companies disregard rare diseases because the development of drugs is deemed 
uneconomical. Therefore, treatment is generally not available or inadequate. Together, these 
issues make rare diseases a major unaddressed public health concern. Applying state of the art 
3D imaging techniques can be helpful in improving the diagnosis of rare diseases with 
recognizable facial characteristics, in part by training healthcare professionals (Hammond et al., 
2005). Moreover, because individuals with rare Mendelian diseases are at higher risk of 
developing common, complex co-morbidities than the general population (Blair et al. 2013), 
detailed phenotyping, such as offered by 3D facial imaging is particularly justified for these 
conditions. 
 Correction of developmental defects or simple desire to improve appearance has given 
rise to a $13 billion cosmetic surgery industry. The second most common cosmetic surgical 
intervention is rhinoplasty, the reshaping of the nose, responsible for expenditures in excess of 
$1 billion in the United States (ASPS). Understanding the genetic determinants of the shape of 
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the nose, as in our study, may result in a more informed design and use of these surgical services, 
or lead to the development of biomaterials which better replicate native tissues. 
 Recognition of individuals by facial characteristics forms an essential element of human 
social interactions as illustrated by the severe social difficulties faced by individuals with 
prosopagnosia (Gruter et al. 2008). In addition providing individuals with information about the 
identity, emotional status, gaze, health and age of their counterparts, recent research suggests that 
facial features have profound influence on the behaviors of both the observer and the observed. 
Specifically, high facial width-to-height ratio in men has been associated with aggression (Carre 
et al., 2008), being less trustworthy (Stirrat et al., 2010) and liability to engage in deception 
(Haselhuhn et al., 2012). Correspondingly, individuals interacting with men of high facial width-
to-height ratios behaved more selfishly (Haselhuhn et al., 2013). Objective evaluation of 
individuals with inherited facial dysmorphisms may help better understand persistent societal 
attitudes towards individuals with inherited disorders. 
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